Pharmaceutical company perspectives on current safety risk communications in Japan

In 1987, a group infection of hepatitis in patients receiving a contaminated fibrinogen product was first reported to the Japanese regulatory agency. Eventually, this serious drug incident involved more than 10,000 cases of infection. In response, the Government of Japan established a responding ins...

Descripción completa

Detalles Bibliográficos
Autores principales: Urushihara, Hisashi, Kobashi, Gen, Masuda, Hideaki, Taneichi, Setsuko, Yamamoto, Michiko, Nakayama, Takeo, Kawakami, Koji, Matsuda, Tsutomu, Ohta, Kaori, Sugimori, Hiroki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921345/
https://www.ncbi.nlm.nih.gov/pubmed/24555168
http://dx.doi.org/10.1186/2193-1801-3-51

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921345/
https://www.ncbi.nlm.nih.gov/pubmed/24555168
http://dx.doi.org/10.1186/2193-1801-3-51

Ejemplares similares